ANGO vs EPAM · rev $292.5M vs P/E 14, rev $4.73B
AngioDynamics Inc (ANGO) versus EPAM Systems Inc (EPAM) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported EPAM revenue for 2024-12-31 was $4.73B. Net income was $454.5M. Revenue was up 0.8% from 2023-12-31 to 2024-12-31. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
ANGO currently screens at market cap $378.5M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
Not investment advice. Open the ANGO and EPAM stock pages for the full models.
Not investment advice.